ReNerve Limited (ASX:RNV)
Australia · Delayed Price · Currency is AUD 0.0740
+0.0030 (4.23%)
At close: Sep 18, 2026
ReNerve Market Cap
ReNerve has a market cap or net worth of 12.23 million as of September 17, 2026. Its market cap has decreased by -26.06% in one year.
Market Cap
12.23M
Enterprise Value
10.95M
Revenue
510.36K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
ChartMarket Cap Chart
Since November 26, 2024, ReNerve's market cap has decreased from 26.95M to 12.23M, a decrease of -54.61%. That is a compound annual growth rate of -35.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 12.23M | -26.06% |
| Dec 31, 2025 | 16.55M | -33.34% |
| Dec 31, 2024 | 24.82M | -7.89% |
| Nov 26, 2024 | 26.95M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Noxopharm | 19.97M |
| EZZ Life Science Holdings | 19.53M |
| Algorae Pharmaceuticals | 18.25M |
| Neurotech International | 15.87M |
| Immuron | 14.21M |
| Cambium Bio | 13.83M |
| Ceryvyn Therapeutics | 13.68M |
| AdAlta | 9.64M |